GUEST SPEAKER: Dr. Amir Gander

UCL School of Pharmacy - (6pm to 8pm)

Amir Gander is the lead individual for Tissue Access for Patient Benefit (TAPb), a UCL initiative to bring surplus human tissue from surgery and biobanks to researchers across UK and internationally. Amir was involved with quality management and regulations and also specialised in the development of bench scale drug fermentation techniques to large production scales at a leading pharmaceutical production plant. TAPb has established a network of researchers interested in tissue from specific disease pathways. In collaboration with the state-of-the-art biobank at the Royal Free Hospital London, they have started to supply tissue (with clinical information) to a number of research companies and have strong ties with public and private sector researchers. 

Session 1 (27/10/16): Introduction - Platforms for translating research

For many scientists, translating research means publishing their work in a journal. These publications are critical in advancing our knowledge, however, a non-scientist audience would find it difficult to interpret these findings, and may therefore be excluded from the advancements scientist are achieving, which may be directly linked to the benefit of the public! In this session, the focus will be held on finding appropriate platforms for getting research known to the public. What organised events exist for bringing ideas forward? How to portray research so that it makes sense to a non-scientist? What are the best ways for exposing science to gain the largest impact?

Session 2 (03/11/16): Developing strategies for public engagement

Sharing great science with an audience can be a difficult task when raised in the lab environment and trained to publish in scientific journals. Where can scientific outreach be taken? What is the best way to convey research to a non-scientific audience?  How is a public outreach event planned and organised? What language needs to be used for the proposed science to be understood by a wide audience and how can the importance of this science be made clear? In this session speakers will demonstrate strategic plans for creating public outreach events. Attendees will learn how to build an image of their work that will be clear and engaging for a wide audience.

Guest Speaker: Devika Wood

Blackett Phys LT1, Imperial College London - (6pm to 8pm)

Devika is a health tech expert who has worked to develop two award winning start-ups in the UK. She has in depth knowledge of how to design, analyse and interpret epidemiological and biomedical research and extensive experience working with industry leaders and key governmental NHS players. After graduating from Kings College London with a BSc in Anatomy, Developmental and Human Biology, Devika completed a master’s degree in Public Health at Imperial and has worked in a number of prestigious health care/ health tech roles in the UK and abroad prior to becoming co-founder and chief medical officer of Vida Care, a home care provider that leverages smart technology to deliver outstanding client-centred care.

Guest Speaker: Tijana Duric

UCL School of Pharmacy - (6pm to 8pm)

GSK is working with many partners to eliminate and control some of the neglected tropical diseases. Tijana has been with GSK for 7 years, entering as a supply chain manager. Her role now is tailored towards private-public partnerships and global health. Tijana looks after the supply planning for albendazole, a treatment for a variety of parasitic worm infections.





Session 3 (21/11/16): Gaining the support of large organisations for promoting scientific research

Findings through scientific research can be grand. In an academic environment, these high impact findings may not necessarily reach the public, even though it may directly affect this audience. Collaborating with large organisations, biotech companies, and the government may jump this hurdle. In this session, invited speakers will demonstrate how to pitch outreach ideas to these organisations, and how to highlight benefits to that organisation in participating in translating scientific research that may not necessarily be a product of their institution.

Session 4 (01/12/16): Turning scientific research into a business

In the final session of the series we explore the process of creating translational start-ups and technologies. Attendees will discover the life-cycle of a start-up and the hurdles that must be overcome. Additionally, risk-assessment and idea development will be explored. Invited speakers will have gone through the process of translating their science through a business, and will guide participants into how they have achieved their success.

Guest Speaker:  Matthew Durdy

UCL School of Pharmacy - (6pm to 8pm)

Matthew joined the Cell and Gene Therapy Catapult in 2012, from the novel therapeutics company Aqix, where he was Chief Executive. He has broad experience in the biotechnology industry leading SMEs, raising finance and commercialising diagnostics, medical devices, and therapeutics for regulated use in the EU. He was also an expert advisor to the World Health Organisation on medical innovation strategy. Matthew was also a Director at the venture capital firm CDC, where he was responsible for due diligence and new investment in their $3.5bn international portfolio.